SHILOH MANNING: Open Payments
NPI 1972536001 · ROY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$623 in 31 payments from 12 companies in 2025. Trend: 2023 $168 · 2024 $390 · 2025 $623
Food & beverage: $623
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $251 |
| Dexcom, Inc. | 2 | $101 |
| Exact Sciences Corporation | 3 | $50 |
| Amgen Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 3 | $37 |
| Tonix Medicines, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VRAYLAR, Dexcom G6 Transmitter, QULIPTA, EVENITY, MOUNJARO, VOQUEZNA, Cologuard Collection Kit, TONMYA.
Industry payments across UT — which companies pay providers there.
